Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global In-vitro Inflammatory Bowel Disease Diagnostic Market


4. Market Overview

4.1. Introduction & Overview

4.2. Product Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, 2018–2030


5. Market Outlook

5.1. Disease Prevalence & Incidence Rate globally with key countries

5.2. Key Industry Developments

5.3. Fecal Biomarkers – Advancement


6. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by Product

6.1. Introduction & Definition

6.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

6.2.1. Assays/Biomarker

6.2.1.1. Calprotectin

6.2.1.2. Lactoferrin

6.2.1.3. Bile Acids

6.2.1.4. H. pylori SA

6.2.1.5. Pancreatic Elastase

6.2.1.6. Others

6.2.2. Analyzers

6.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by Product


7. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by End-user

7.1. Introduction & Definition

7.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$) Forecast, by End-user, 2018–2030

7.2.1. Diagnostic Laboratories

7.2.2. Hospitals

7.2.3. Research Institutes

7.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by End-user


8. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by Region


9. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast

9.1. Introduction

9.2. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

9.2.1. Assays/Biomarker

9.2.1.1. Calprotectin

9.2.1.2. Lactoferrin

9.2.1.3. Bile Acids

9.2.1.4. H. pylori SA

9.2.1.5. Pancreatic Elastase

9.2.1.6. Others

9.2.2. Analyzers

9.3. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

9.3.1. Diagnostic Laboratories

9.3.2. Hospitals

9.3.3. Research Institutes

9.4. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country, 2018–2030

9.4.1. U.S.

9.4.2. Canada

9.5. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis

9.5.1. By Product

9.5.2. By End-user

9.5.3. By Country


10. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast

10.1. Introduction

10.2. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

10.2.1. Assays/Biomarker

10.2.1.1. Calprotectin

10.2.1.2. Lactoferrin

10.2.1.3. Bile Acids

10.2.1.4. H. pylori SA

10.2.1.5. Pancreatic Elastase

10.2.1.6. Others

10.2.2. Analyzers

10.3. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

10.3.1. Diagnostic Laboratories

10.3.2. Hospitals

10.3.3. Research Institutes

10.4. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis

10.5.1. By Product

10.5.2. By End-user

10.5.3. By Country/Sub-region


11. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast

11.1. Introduction

11.2. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

11.2.1. Assays/Biomarker

11.2.1.1. Calprotectin

11.2.1.2. Lactoferrin

11.2.1.3. Bile Acids

11.2.1.4. H. pylori SA

11.2.1.5. Pancreatic Elastase

11.2.1.6. Others

11.2.2. Analyzers

11.3. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

11.3.1. Diagnostic Laboratories

11.3.2. Hospitals

11.3.3. Research Institutes

11.4. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis

11.5.1. By Product

11.5.2. By End-user

11.5.3. By Country/Sub-region

12. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast

12.1. Introduction

12.2. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

12.2.1. Assays/Biomarker

12.2.1.1. Calprotectin

12.2.1.2. Lactoferrin

12.2.1.3. Bile Acids

12.2.1.4. H. pylori SA

12.2.1.5. Pancreatic Elastase

12.2.1.6. Others

12.2.2. Analyzers

12.3. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

12.3.1. Diagnostic Laboratories

12.3.2. Hospitals

12.3.3. Research Institutes

12.4. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis

12.5.1. By Product

12.5.2. By End-user

12.5.3. By Country/Sub-region

13. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast

13.1. Introduction

13.2. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

13.2.1. Assays/Biomarker

13.2.1.1. Calprotectin

13.2.1.2. Lactoferrin

13.2.1.3. Bile Acids

13.2.1.4. H. pylori SA

13.2.1.5. Pancreatic Elastase

13.2.1.6. Others

13.2.2. Analyzers

13.3. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

13.3.1. Diagnostic Laboratories

13.3.2. Hospitals

13.3.3. Research Institutes

13.4. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis

13.5.1. By Product

13.5.2. By End-user

13.5.3. By Country/Sub-region


14. Competition Landscape

14.1. Market Position Analysis, by Company, 2019

14.2. Company Profiles

14.2.1. DiaSorin S.p.A

14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.1.2. Company Financials

14.2.1.3. Growth Strategies

14.2.1.4. SWOT Analysis

14.2.2. F. Hoffmann-La Roche Ltd

14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.2.2. Company Financials

14.2.2.3. Growth Strategies

14.2.2.4. SWOT Analysis

14.2.3. Siemens Healthineers AG

14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.3.2. Company Financials

14.2.3.3. Growth Strategies

14.2.3.4. SWOT Analysis

14.2.4. Abbott

14.2.4.1. Company Overview (HQ, Business Segments)

14.2.4.2. Company Financials

14.2.4.3. Growth Strategies

14.2.4.4. SWOT Analysis

14.2.5. Quidel Corporation

14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.5.2. Company Financials

14.2.5.3. Growth Strategies

14.2.5.4. SWOT Analysis

14.2.6. B?HLMANN Laboratories AG

14.2.6.1. Company Overview (HQ, Business Segments)

14.2.6.2. Growth Strategies

14.2.6.3. SWOT Analysis

14.2.7. American Laboratory Products Company (ALPCO)

14.2.7.1. Company Overview (HQ, Business Segments)

14.2.7.2. Growth Strategies

14.2.7.3. SWOT Analysis

14.2.8. Certest Biotec SL

14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.8.2. Growth Strategies

14.2.8.3. SWOT Analysis

14.2.9. Biosystems S.A.

14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.9.2. Growth Strategies

14.2.9.3. SWOT Analysis



List of Figures



Figure 01: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by Product, 2019

Figure 03: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by End-user, 2019

Figure 04: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by Region, 2019

Figure 05: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Product, 2019 and 2030

Figure 06: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn), by Assays/Biomarkers, 2018–2030

Figure 07: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn), by Analyzers, 2018–2030

Figure 08: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2020–2030

Figure 09: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 10: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn), by Diagnostic Laboratories, 2018–2030

Figure 11: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn), by Hospitals, 2018–2030

Figure 12: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn), by Research Institutes, 2018–2030

Figure 13: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 14: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Region, 2019 and 2030

Figure 15: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Analysis, by Region

Figure 16: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 17: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Country, 2019 and 2030

Figure 18: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Country, 2020–2030

Figure 19: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Product, 2019 and 2030

Figure 20: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Product, 2020–2030

Figure 21: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 22: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user2020–2030

Figure 23: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 24: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 25: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 26: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Product, 2019 and 2030

Figure 27: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Product, 2020–2030

Figure 28: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 29: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 30: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 31: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 32: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 33: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Product, 2019 and 2030

Figure 34: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Product, 2020–2030

Figure 35: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 36: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 37: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 38: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 39: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 40: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Product, 2019 and 2030

Figure 41: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Product, 2020–2030

Figure 42: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 43: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user 2020–2030

Figure 44: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 45: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 46: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 47: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share (%), by Product, 2019 and 2030

Figure 48: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness, by Product, 2020–2030

Figure 49: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 50: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user 2020–2030

Figure 51: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Analysis, by Top Company Ranking, 2019


List of Tables



Table 01: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 02: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030

Table 03: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 04: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 05: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 06: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 07: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarker, 2018–2030

Table 08: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 09: Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 10: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 11: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030

Table 12: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 13: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 14: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 15: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030

Table 16: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 17: Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 18: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 19: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030

Table 20: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 21: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 22: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 23: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarker, 2018–2030

Table 24: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030